Pure Global Cannabis Inc.
Pure Global Cannabis Inc.
Your view on PRCNF
Overview
What the company does, where it operates, and who runs it.
About Pure Global Cannabis Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Malay Panchal
- Headquarters
- 418-2095 Lake Shore Boulevard West, Toronto, ON, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Malay Panchal
- Headquarters
- 418-2095 Lake Shore Boulevard West, Toronto, ON, CA
Pure Global Cannabis Inc. produces cannabis products for the medical and adult-use markets in Canada.
The company provides cannabis products, such as dried flower, cannabis oils, soft gels and capsules, seedlings and clones, vape pen cartridges, topicals, sublingual strip/spray, transdermal patch, and edibles and beverages, as well as wellness products.
It offers its products under the PureSinse, SPARK Medical Cannabis clinics, and The Great Canadian Hemp Company brands. The company serves medical, pharmaceutical, wellness, health and beauty, natural health, food and beverage, and recreational legal markets. Pure Global Cannabis Inc. is headquartered in Toronto, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Pure Global Cannabis Inc., and the rating behind it. PRCNF last traded at $0.0000; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Pure Global Cannabis Inc.. Starting points for Pure Global Cannabis Inc.: EPS -$0.17, beta -3.15 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Pure Global Cannabis Inc.. Pure Global Cannabis Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Pure Global Cannabis Inc.. Trailing twelve-month EPS for Pure Global Cannabis Inc. stands at -$0.17. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Pure Global Cannabis Inc.. Pure Global Cannabis Inc. has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Pure Global Cannabis Inc. valued side by side against its closest peers. Pure Global Cannabis Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Pure Global Cannabis Inc., and how their positions are changing. At a $1,616 market value, institutional positions materially move Pure Global Cannabis Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Pure Global Cannabis Inc. executives and directors. Shares of Pure Global Cannabis Inc. have traded between $0.0000 and $0.0000 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Pure Global Cannabis Inc.. Pure Global Cannabis Inc. is a $1,616 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Pure Global Cannabis Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Pure Global Cannabis Inc.. Coverage tracks Pure Global Cannabis Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.